Navigation

  • Skip to Content
Council of Europe
WWW.COE.INT
Human Rights Democracy Rule of Law
About us
Council of Europe at a glance
The Council of Europe: key facts
Achievements and History
Jobs and Traineeships
Home
Human Rights
Democracy
Rule of Law
Administrative entities
Secretary General
Deputy Secretary General
Chairmanship
Committee of Ministers
Parliamentary Assembly
Congress of Local and Regional Authorities
European Court of Human Rights
Commissioner for Human Rights
Conference of INGOs
Monitoring bodies
Private Office
Treaty Office
46 Member States
Theme files
Newsroom
Events
Bookshop
Online resources
Contact
Intranet
English
Choose language
Français
English
Connect
Search
Council of Europe at a glance
The Council of Europe: key facts
Achievements and History
Jobs and Traineeships
Home
Human Rights
Democracy
Rule of Law
Administrative entities
Secretary General
Deputy Secretary General
Chairmanship
Committee of Ministers
Parliamentary Assembly
Congress of Local and Regional Authorities
European Court of Human Rights
Commissioner for Human Rights
Conference of INGOs
Monitoring bodies
Private Office
Treaty Office
46 Member States
Theme files
Newsroom
Events
Bookshop
Online resources
Contact
Intranet
Avenue de l'Europe
F-67075 Strasbourg Cedex
Tel. +33 (0)3 88 41 20 00
www.coe.int
European Directorate for the Quality of Medicines & HealthCare

European Directorate for the Quality of Medicines & HealthCare

  • Home
  • EDQM
    • Back
    • About us
      • Back
      • Newsroom
        • Back
        • All EDQM press releases
      • Vision, mission & values
      • History
      • Structure
      • Memoranda of Understanding and Agreements
      • Management Systems
        • Back
        • Quality Management
      • Newsletter
    • Careers
      • Back
      • Jobs and careers at EDQM
  • Medicines
    • Back
    • European Pharmacopoeia (Ph. Eur.)
      • Back
      • Newsroom European Pharmacopoeia
      • Focus
        • Back
        • Biotherapeutics
        • Alternatives to animal testing
          • Back
          • Report from the ad hoc meeting on the 3Rs
          • BSP programme for 3RS
          • Replacement, Reduction and Refinement of animal testing (3Rs): latest achievements
      • The Ph. Eur. work programme
        • Back
        • Where to find: The Knowledge database
        • Elaboration & Revision
        • The Ph. Eur. Work Programme
      • Pharmacopoeial Harmonisation
        • Back
        • Harmonisation status for Excipient monographs (PDG)
        • Harmonisation status for General Texts (PDG)
      • Find information on
        • Back
        • Ph. Eur. Technical Guides
        • Databases
        • FAQ - HelpDesk Ph. Eur. texts
      • CombiStats
        • Back
        • CombiStats: What's new in the web application?
        • Have a question about CombiStats?
      • The European Pharmacopoeia
        • Back
        • European Pharmacopoeia - Background and Mission
        • The European Pharmacopoeia - Membership & Observership
        • The European Pharmacopoeia Commission
        • Groups of Experts and Working Parties
        • European Pharmacopoeia (Ph. Eur.) 11th Edition
      • Standard Terms Database
      • How to participate in the work of the Ph. Eur.
        • Back
        • Join the Network!
        • Submitting drafts and requests for revision
        • Comment on drafts (Pharmeuropa)
        • Pharmeuropa, Pharmeuropa Bio & Scientific Notes
    • Biological Standardisation Programme (BSP)
      • Back
      • The BSP Steering Committee
      • BSP Work Programme
      • BSP programme for 3Rs
      • Reference Standards from the BSP programme adopted in 2023
    • Reference Standards (RS)
      • Back
      • Ph. Eur. Reference Standards
        • Back
        • Ph. Eur. Reference Standards: Purpose and use
        • Ph. Eur. Reference Standards: Orders and Catalogue
      • WHO RS
        • Back
        • WHO International Standards for Antibiotics (ISA) : Purpose & Use
        • WHO ISA Orders & Catalogue
        • WHO International Chemical Reference Substances (ICRS) : Purposes & Use
        • WHO ICRS Orders & Catalogue
      • FAQ & HelpDesk Reference Standards (RS)
      • Safety Information for Reference Standards: Safety Data Sheets (SDS) & Biohazard Statements
    • Certification of Suitability (CEP)
      • Back
      • Newsroom Certification of suitability
      • About the Procedure
        • Back
        • Certification - Background & Legal Framework
        • Mission and organisation
        • What is the CEP 2.0?
        • The Inspection Programme
        • EDQM and real-time remote GMP inspections of API manufacturers during the COVID-19 pandemic: innovation overcoming adversity
      • How to apply
        • Back
        • New Applications
          • Back
          • Submit A New Application
          • Content of the Dossier
          • Quality Overall Summary (QOS) for CEP applications
        • Notifications, Revisions, Renewals and Sister Files
          • Back
          • Classification of changes
            • Back
            • Submission of Nitrosamine impurity risk assessment
          • Submit changes
          • Sister files
        • Technical advice & one-to-one meetings
        • Submission format and electronic submission
      • Find information on
        • Back
        • Certification Policy Documents & Guidelines
        • Actions on CEPs
        • CERTIFICATION Database
        • KNOWLEDGE Database
        • Fees for Certificates of Suitability (CEP)
        • FAQ & Helpdesk Certification and CEPs
      • Consultation space
    • OMCL Network
      • Back
      • Newsroom OMCL
      • General Activities
        • Back
        • OMCL - Background and mission
          • Back
          • Discover how Official Medicines Control Laboratories contribute to protect your health in Europe and beyond
        • Market Surveillance Studies (MSS)
        • Quality Management (QM) Programme
          • Back
          • Quality Management (QM) Documents
        • Physico-chemical and Biological PTS
          • Back
          • List of Proficiency Testing Scheme (PTS) Studies planned for 2025
          • Physico-chemical & Biological PTS Fees
      • Programmes EU/EEA Network
        • Back
        • Human Biologicals (OCABR)
          • Back
          • Questions and answers on OCABR
          • Batch Release for Human Biologicals: vaccines, blood and plasma derivatives
        • Veterinary Biologicals (OCABR/OBPR)
          • Back
          • Guidelines for EU OCABR for IVMPs
        • MRP/DCP Post Marketing Surveillance Scheme
          • Back
          • MRP/DCP Product Testing Database
        • CAP Sampling & Testing Programme
      • Working group activities
        • Back
        • Testing of Active Pharmaceutical Ingredients (APIs)
        • Quality Monitoring of Stockpiled Medicines
          • Back
          • Stockpiling of Medicines: Position Paper
          • Stockpiling of Medicines: Technical Guideline
        • OMCL Gene Therapy Working Group
        • Testing of falsified / illegal medicines
          • Back
          • Previous Technical OMCL Falsified Medicines Training Sessions
          • Previous press releases
        • Nitrosamine testing activities of the OMCL Network
      • FAQ & HelpDesk - OMCL network
    • N-nitrosamine contamination in brief
      • Back
      • Newsroom Nitrosamine contamination
    • Anti-falsification activities
      • Back
      • Newsroom - Anti-falsification activities
      • Background and mission - Anti-falsification activities
      • Work programme CD-P-PH/CMED
      • The MEDICRIME Convention
      • Publications on falsified medical products and related crimes
      • Single Points of Contact (SPOC) Network
    • Classification of medicines
      • Back
      • Newsroom Classification of medicines
      • CD-P-PH/PHO - Classification of Medicines as Regards their Supply
        • Back
        • Work programme CD-P-PH/PHO
        • CD-P-PH/PHO - Database and publications
        • Resolution CM/Res(2018)1 on the classification of medicines as regards their supply
      • FAQ & HelpDesk - Pharmaceuticals
    • Pharmaceutical Care
      • Back
      • Newsroom Pharmaceutical care
      • CD-P-PH/PC - Pharmaceutical Practices and Pharmaceutical Care
        • Back
        • Work programme: setting quality and safety standards in pharmaceutical practices and pharmaceutical care
        • Activities and projects - CD-P-PH/PC
        • Guidance documents and publications - CD-P-PH/PC
        • Resolutions in the field of pharmaceutical practices and pharmaceutical care
      • European Committee on Pharmaceuticals and Pharmaceutical Care (CD-P-PH)
      • HelpDesk - Pharmaceutical Care
    • European Paediatric Formulary
      • Back
      • Background & Mission - Paediatric Formulary
      • FAQ & HelpDesk - Paediatric Formulary
    • EDQM initiatives on medicine shortages
      • Back
      • Technical recommendations of the European drug Shortages Formulary Working Party
    • EDQM activities on borderline products
  • Substances of human origin
    • Back
    • Blood Transfusion
      • Back
      • Newsroom Blood Transfusion
      • Background & Mission
      • Organisation & Work programme
      • Areas of work – Blood
        • Back
        • Plasma Supply Continuity
        • Optimal use of blood components and plasma-derived medicinal products
        • Blood Quality Management Programme
          • Back
          • Blood Quality Management programme (B-QM)
          • Blood Proficiency Testing Scheme (B-PTS)
            • Back
            • List of Blood Proficiency Testing Scheme (B-PTS) for 2025
          • Ordering information for Blood Proficiency Testing Scheme (B-PTS) studies
        • Blood Supply Contingency and Emergency Plan (B-SCEP)
      • Legal framework – Blood
      • Publications - Blood
        • Back
        • Guide to the preparation, use and quality assurance of blood components
        • Reports
      • FAQ & HelpDesk
    • Organs, tissues and cells
      • Back
      • Newsroom - Organs, tissues and cells
      • Organs, tissues and cells - Background & Mission
      • Organisation & Work Programme
      • Areas of work - Transplantation
      • Legal Framework
        • Back
        • Signatures and ratifications of Treaty 216
      • Organs, tissues and cells - Publications
        • Back
        • Position Papers & Reports
        • Newsletter Transplant
        • Guide to the quality and safety of tissues and cells for human application
        • Guide to the quality and safety of organs for transplantation
        • Organ, Tissues and Cells of human origin: Council of Europe resolutions, recommendations and reports – 3rd Edition (2017)
        • Guide for the implementation of the principle of prohibition of financial gain with respect to the human body and its parts from living or deceased donors (2018)
        • Booklets
        • Publication - Other Languages - Organs, tissues and cells
      • FAQ & HelpDesk - Organs, tissues and cells
  • Consumer health
    • Back
    • Cosmetics & tattoos
      • Back
      • Newsroom Cosmetics & tattoos
      • Tattoos and permanent make-up - Focus and activities
      • Cosmetics and consumer health
        • Back
        • About Cosmetics and consumer health
        • European legal framework for cosmetic products
      • Publications on cosmetic products and tattoo inks
        • Back
        • Cosmetics for children under the age of three
        • Guidance on essential oils in cosmetic products
      • FAQ & HelpDesk - Cosmetics and Tattoos
    • Official Cosmetics Control Laboratories (OCCL)
      • Back
      • The Network of Official Cosmetics Control Laboratories (OCCLs)
      • Discover the OCCLs and their achievements
      • Members of the Network of Official Cosmetics Control Laboratories (OCCLs)
      • Activities of the OCCL Network : coordinating surveillance and enhancing testing capacity
        • Back
        • OCCLs: analytical methods
        • Market surveillance studies in cosmetics (COS MSS)
        • Proficiency testing scheme studies in cosmetics
      • OCCLs in practice, their work and experience
        • Back
        • Special focus on children’s safety: make-up and cosmetics
        • Cutting edge expertise for testing cosmetics
        • Detecting cannabinoids (THC, CBD & CBN) in cosmetic products
        • Are tattoo inks and products safe?
        • Austrian agency for health and food safety, AGES
    • Food contact materials and articles
      • Back
      • Newsroom Food contact materials and articles
      • Food contact materials and articles
        • Back
        • Resolutions & Policy statements
      • Publications on food contact materials and articles
        • Back
        • Multi-analyte methods for the determination of substances migrating from printing inks to dry food or food simulants
        • Paper and board used in food contact materials and articles
        • Metals and alloys used in food contact materials and articles
        • Documentation supporting the compliance and safety of food contact materials and articles
      • FAQ & HelpDesk Food contact materials and articles
  • Products & services
    • Back
    • Newsroom Products and services
    • Ordering Reference Standards & Publications
    • Sales information
    • CombiStats
    • EDQM publications
      • Back
      • How to place an order for EDQM Publications
      • How to register your subscription key (en anglais)
      • European Pharmacopoeia 11th Edition
      • Pharmeuropa
      • Technical guides Ph. Eur.
      • Blood guide
      • Organs guide
      • Tissues and cells technical guide
      • Cosmetics & Tattooing
      • Food contact materials and articles guide
      • Overview of pharmacopoeia related products and services
      • Online access for Freepub publications
    • EDQM reference standards
      • Back
      • How to place an order for EDQM RS
      • Ph. Eur. RS Orders & catalogue
      • WHO ISA Orders & catalogue
      • WHO ICRS Orders & Catalogue
      • Safety Data Sheets
    • FAQ & HelpDesk - EDQM all activities
      • Back
      • FAQ & HelpDesk Reference Standards (RS)
      • FAQ & HelpDesk - Publications
      • FAQ & HelpDesk Electronic Publications - Technical Support
  • Events & training
    • Back
    • Upcoming events
      • Back
      • Medication reviews in Europe and their role in optimising the use of medicines by patients
      • 35th Regional ISBT Congress
      • Sterile substance CEP webinar
      • CPhI China 2025
      • Certified for success: using the CEP Procedure to elevate quality and drive trust
    • Past events, training and campaigns
      • Back
      • European Donation Day (EDD)
        • Back
        • Institutions for organ donation and transplantation in our member states
        • European Donation Day 2024
      • EDQM Open Day – A day for all to enjoy!
      • Celebrating 60 years of excellence in public health protection
        • Back
        • Celebrating 60 years of excellence in public health protection - Communication kit
        • Celebrating 60 years of excellence in public health protection - Speaker profiles
        • Questions and answers from the "Tomorrow" session
      • European Pharmacopoeia 11th Edition Conference highlights
      • EDQM Blood Conference
      • EDQM Stakeholder Event - Plasma Supply Continuity
    • Latest e-learning resources
      • Back
      • e-Learning catalogue
        • Back
        • 2024 EDQM Virtual Training Programme: independent modules on Ph. Eur., Reference Standards and CEP Procedure
    • FAQ & HelpDesk - Events and visits
      • Back
      • Information for Event Participants
      • Webinar System Requirements
  • Contact
    • Back
    • Helpdesk
    • Contact the Webmaster
    • Media enquiries
    • Contact the EDQM
    • Stay connected with the EDQM
You are here:
  1. European Directorate for the Quality of Medicines & HealthCare
  2. Medicines
  3. OMCL Network

OMCL Network

  • Collaborative study on validation of an ELISA method for determination of physical particle titre of AAV2 vectors: outcome published
    Dec 5, 2024

    Collaborative study on validation of an ELISA method for determination of physical particle titre of AAV2 vectors: outcome published

    EDQM Strasbourg, France 05/12/2024

    The Gene Therapy Working Group (GTWG) of the General European Official Medicines Control...

  • OMCL Network welcomes Türkiye as a full member
    Nov 5, 2024

    OMCL Network welcomes Türkiye as a full member

    EDQM Strasbourg, France 05/11/2024

    The Analysis and Control Laboratories Department of the Turkish Medicines and Medical Devices...

See all OMCL related news >
FIND YOUR WAY - TOPICS

General activities

Background & Mission of the General European OMCL Network (GEON)

Quality Management (QM) Programme

Physico-chemical & Biological PTS

Market Surveillance Studies (MSS)

Nitrosamine testing activities of the OMCL Network

Working Group activities

Testing of Active Pharmaceutical Ingredients (APIs)

Testing of Falsified / Illegal medicines within the GEON

Quality Monitoring of Stockpiled Medicines

OMCL Gene Therapy working group

Programmes EU/EEA Network

MRP/DCP Post Marketing Surveillance Scheme

CAP Sampling & Testing Programme

Human Biologicals (OCABR)

Veterinary Biologicals (OCABR/OBPR)

CombiStats computer software

CombiStats

Useful Links
Quality Management (QM) Documents

Quality Management (QM) Documents

Human OCABR Guidelines

Human OCABR Guidelines

Veterinary OCABR Guidelines

Veterinary OCABR Guidelines

FAQ & HelpDesk

FAQ & HelpDesk

PTS Studies

PTS Studies

eLearning

eLearning

OMCLs at a Glance
  • The European Network of Offical Medicines Control Laboratories (OMCLs) Brochure
  • OMCL Videoclip 
Upcoming events
3 octobre 2024

PDG stakeholder event – The PDG is going global

2023 EDQM annual report

2023 EDQM annual report

Focus


30th anniversary of the OMCL Network – Celebrating the success of international collaboration for safe medicines at the 29th GEON meeting

Video
The story of the EDQM
26 Jun 2024 09:21:00

The story of the EDQM

News
EDQM 02/06/2023 Strasbourg, France

Ph. Eur. Commission keeps pace with veterinary vaccine development efforts

EDQM 27/02/2023 Strasbourg, France

Independent control of COVID-19 vaccines: article co-authored by the EDQM and members of the OCABR Network published in npj Vaccines

11th Edition at a glance

11th Edition at a glance

EDQM - Follow us

Council of Europe Health

EDQM Newsletter

Click here to subscribe.

ABOUT US

  • About us
  • Vision, mission & values
  • Members & observers
  • Careers
  • Calls for tender

USEFUL INFORMATION

  • All news
  • All events
  • Databases
  • Product & services
  • Sitemap

CLIENT ACCESS

  • Pharmeuropa
  • Pharmeuropa Bio & Sc. Notes
  • Ph. Eur. 11th edition
  • Standard terms
  • Blood & organs
  • European Paediatric Formulary
  • Consumer health
  • Terms & conditions

FOLLOW US

  • Pharmeuropa alerts
  • Stay connected
  • RSS Feed

PARTNERS

  • EU Commission
  • EMA
  • HMA
  • WHO

CONTACT US

  • Press enquiries
  • Contact details
  • Visit the EDQM
  • FAQ & HelpDesk
  • EDQM Service Desk (staff only) 
logo Council of Europe Council of Europe Portal

About

  • Who we are
  • Human Rights
  • Democracy
  • Rule of Law
  • European Convention on Human Rights
  • Jobs and Traineeships
  • Visit us

Follow us

  • Bluesky
  • Facebook
  • X (Twitter)
  • Instagram
  • LinkedIn
  • Youtube
  • Flickr
  • Podcasts

Contacts

  • Private office of the Secretary General
  • Contact for the media
  • External offices
  • Newsletters
  • Procurement
  • Grants
  • Patronage
  • Report wrongdoing
  • Oversight Advisory Committee
  • Ethics Officer

Multimedia

  • Newsroom
  • Human Rights Channel
  • Photo galleries
  • Online bookshop
  • Online resources
  • Campaigns

USEFUL LINKS

  • Archives
  • Archived web pages
  • Amicale
  • Administrative Tribunal
  • Accessibility
  • Sitemap
  • Access
logo Council of Europe
 Intranet
Council of Europe,
Avenue de l'Europe F-67075 Strasbourg Cedex, France -
Tel. +33 (0)3 88 41 20 00
Disclaimer - © Council of Europe 2025 - © Photo credit - Contact - RSS